Prostate volume contouring: A 3D analysis of segmentation using 3DTRUS, CT, and MR

International Journal of Radiation Oncology Biology Physics

Volumn 67, Issue 4, 2007, Pages 1238-1247

  Smith, Wendy L ^a   Lewis, Craig ^b   Bauman, Glenn ^b,c   Rodrigues, George ^b,c   D'Souza, David ^b,c   Ash, Robert ^b,c   Ho, Derek ^c   Venkatesan, Varagur ^b,c   Downey, Dónal ^d   Fenster, Aaron ^c,d  

^a TOM BAKER CANCER CENTRE   (Canada)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

^c WESTERN UNIVERSITY   (Canada)

^d ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

3D ultrasound; Brachytherapy; Computed tomography; Magnetic resonance; Prostate

Indexed keywords

COMPUTERIZED TOMOGRAPHY; IMPLANTS (SURGICAL); MAGNETIC RESONANCE IMAGING; MEDICAL IMAGING; PATIENT TREATMENT; ULTRASONICS;

3D ULTRASOUND; BRACHYTHERAPY; PROSTATE;

TUMORS;

ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DEVICE; HUMAN; IMAGE ANALYSIS; MALE; MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE VOLUME; RECTUM; REPRODUCIBILITY; THREE DIMENSIONAL IMAGING; TRANSRECTAL ULTRASONOGRAPHY;

BRACHYTHERAPY; HUMANS; IMAGING, THREE-DIMENSIONAL; IODINE RADIOISOTOPES; MAGNETIC RESONANCE IMAGING; MALE; OBSERVER VARIATION; PROSTATE; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 33847333327     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.11.027     Document Type: Article

References (55)

1. Stock R.G., Stone N.N., Tabert A., et al. A dose-response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys 41 (1998) 101-108
2. Parker C.C., Damyanovich A., Haycocks T., et al. Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration. Radiother Oncol 66 (2003) 217-224
3. Kollmeier M.A., Stock R.G., and Stone N. Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: Importance of patient selection and implant quality. Int J Radiat Oncol Biol Phys 57 (2003) 645-653
4. Potters L., Morgenstern C., Calugaru E., et al. 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol 173 (2005) 1562-1566
5. D'Souza W.D., Thames H.D., and Kuban D.A. Dose-volume conundrum for response of prostate cancer to brachytherapy: Summary dosimetric measures and their relationship to tumor control probability. Int J Radiat Oncol Biol Phys 58 (2004) 1540-1548
6. Papagikos M.A., Deguzman A.F., Rossi P.J., et al. Dosimetric quantifiers for low-dose-rate prostate brachytherapy: Is V(100) superior to D(90)?. Brachytherapy 4 (2005) 252-258
7. Amdur R.J., Gladstone D., Leopold K.A., et al. Prostate seed implant quality assessment using MR and CT image fusion. Int J Radiat Oncol Biol Phys 4 (1999) 67-72
8. Crook J., McLean M., Yeung I., et al. MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy. Brachytherapy 3 (2004) 55-60
9. Dubois D.F., Prestidge B.R., Hotchkiss L.A., et al. Intraobserver and interobserver variability of MR imaging- and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy. Radiology 207 (1998) 785-789
10. Haworth A., Ebert M., St Clair S., et al. Impact of selection of post-implant technique on dosimetry parameters for permanent prostate implants. Brachytherapy 4 (2005) 146-153
11. Parker C.C., Damyanovich A., Haycocks T., et al. Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration. Radiother Oncol 66 (2003) 217-224
12. Prete J.J., Prestidge B.R., Bice W.S., et al. Comparison of MRI- and CT-based post-implant dosimetric analysis of transperineal interstitial permanent prostate brachytherapy. Radiat Oncol Investig 6 (1998) 90-96
13. Polo A., Cattani F., Vavassori A., et al. MR and CT image fusion for postimplant analysis in permanent prostate seed implants. Int J Radiat Oncol Biol Phys 60 (2004) 1572-1579
14. Smith S., Wallner K., Merrick G., et al. Interpretation of pre- versus postimplant TRUS images. Med Phys 30 (2003) 920-924
15. Terris M.K., and Stamey T.A. Determination of prostate volume by transrectal ultrasound. J Urol 145 (1991) 984-987
16. Tewari A., Indudhara R., Shinohara K., et al. Comparison of transrectal ultrasound prostatic volume estimation with magnetic resonance imaging volume estimation and surgical specimen weight in patients with benign prostatic hyperplasia. J Clin Ultrasound 24 (1996) 169-174
17. Sosna J., Rofsky N.M., Gaston S.M., et al. Determinations of prostate volume at 3-Tesla using an external phased array coil: Comparison to pathologic specimens. Acad Radiol 10 (2003) 846-853
18. Tong S., Cardinal H.N., McLoughlin R.F., et al. Intra- and inter-observer variability and reliability of prostate volume measurement via two-dimensional and three-dimensional ultrasound imaging. Ultrasound Med Biol 24 (1998) 673-681
19. Hoffelt S.C., Marshall L.M., Garzotto M., et al. A comparison of CT scan to transrectal ultrasound-measured prostate volume in untreated prostate cancer. Int J Radiat Oncol Biol Phys 57 (2003) 29-32
20. McLaughlin P.W., Narayana V., Drake D.G., et al. Comparison of MRI pulse sequences in defining prostate volume after permanent implantation. Int J Radiat Oncol Biol Phys 54 (2002) 703-711
21. Rasch C., Barillot I., Remeijer P., et al. Definition of the prostate in CT and MRI: A multiobserver study. Int J Radiat Oncol Biol Phys 43 (1999) 57-66
22. Roach III M., Faillace-Akazawa P., Malfatti C., et al. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 35 (1996) 1011-1018
23. Milosevic M., Voruganti S., Blend R., et al. Magnetic resonance imaging (MRI) for localization of the prostatic apex: comparison to computed tomography (CT) and urethrography. Radiother Oncol 47 (1998) 277-284
24. Seddon B., Bidmead M., Wilson J., et al. Target volume definition in conformal radiotherapy for prostate cancer: Quality assurance in the MRC RT-01 trial. Radiother Oncol 56 (2000) 73-83
25. Sech S., Montoya J., Girman C.J., et al. Interexaminer reliability of transrectal ultrasound for estimating prostate volume. J Urol 166 (2001) 125-129
26. Fiorino C., Reni M., Bolognesi A., et al. Intra- and inter-observer variability in contouring prostate and seminal vesicles: Implications for conformal treatment planning. Radiother Oncol 47 (1998) 285-292
27. Debois M., Oyen R., Maes F., et al. The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. Int J Radiat Oncol Biol Phys 45 (1999) 857-865
28. Berthelet E., Liu M.C., Agranovich A., et al. Computed tomography determination of prostate volume and maximum dimensions: A study of interobserver variability. Radiother Oncol 63 (2002) 37-40
29. Tong S., Downey D.B., Cardinal H.N., et al. Three-dimensional ultrasound prostate imaging system. Ultrasound Med Biol 22 (1996) 735-746
30. Fenster A., Downey D.B., and Cardinal H.N. Three-dimensional ultrasound imaging. Phys Med Biol 46 (2001) R67-R99
31. Alyassin A.M., Lancaster J.L., Downs III J.H., et al. Evaluation of new algorithms for the interactive measurement of surface area and volume. Med Phys 21 (1994) 741-752
32. Blake C.C., Elliot T.L., Slomka P.J., et al. Variability and accuracy of measurements of prostate brachytherapy seed position in vitro using three-dimensional ultrasound: An intra- and inter-observer study. Med Phys 27 (2000) 2788-2795
33. Stroom J.C., Korevaar G.A., Koper P.C., et al. Multiple two-dimensional versus three-dimensional PTV definition in treatment planning for conformal radiotherapy. Radiother Oncol 47 (1998) 297-302
34. Aarnink R.G., De La Rosette J.J., Debruyne F.M., et al. Reproducibility of prostate volume measurements from transrectal ultrasonography by an automated and a manual technique. Br J Urol 78 (1996) 219-223
35. Chenven E.S., Glazier D.B., Krisch E.B., et al. Evaluation of prostate volume by transrectal ultrasonography for use in a brachytherapy program. Urology 58 (2001) 752-755
36. Ladak H., Mao F., Wang Y., et al. Prostate boundary segmentation from 2D ultrasound images. Med Phys 27 (2000) 1777-1788
37. Wang Y., Cardinal H.N., Downey D.B., et al. Semiautomatic three-dimensional segmentation of the prostate using two-dimensional ultrasound images. Med Phys 30 (2003) 887-897
38. Hu N., Downey D., Fenster A., et al. Prostate boundary segmentation from 3D ultrasound images. Med Phys 30 (2003) 1648-1659
39. Milonas D., Trumbeckas D., and Juska P. The importance of prostatic measuring by transrectal ultrasound in surgical management of patients with clinically benign prostatic hyperplasia. Medicina (Kaunas) 39 (2003) 860-866
40. Zlotta A.R., Djavan B., Damoun M., et al. The importance of measuring the prostatic transition zone: An anatomical and radiological study. BJU Int 84 (1999) 661-666
41. Wolff J.M., Boeckmann W., Mattelaer P., et al. Determination of prostate gland volume by transrectal ultrasound: Correlation with radical prostatectomy specimens. Eur Urol 28 (1995) 10-12
42. Hricak H., Jeffrey R.B., Dooms G.C., et al. Evaluation of prostate size: a comparison of ultrasound and magnetic resonance imaging. Urol Radiol 9 (1987) 1-8
43. Narayana V., Roberson P.L., Winfield R.J., et al. Impact of ultrasound and computed tomography prostate volume registration on evaluation of permanent prostate implants. Int J Radiat Oncol Biol Phys 39 (1997) 341-346
44. Prestidge B.R., Bice W.S., Kiefer E.J., et al. Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy. Int J Radiat Oncol Biol Phys 40 (1998) 1111-1115
45. Solhjem M.C., Davis B.J., Pisansky T.M., et al. Prostate volume measurement by transrectal ultrasound and computed tomography before and after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 60 (2004) 767-776
46. Chen M.E., Johnston D.A., Tang K., et al. Detailed mapping of prostate carcinoma foci: Biopsy strategy implications. Cancer 89 (2000) 1800-1809
47. Lee W.R., Roach III M., Michalski J., et al. Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy. Int J Radiat Oncol Biol Phys 54 (2002) 457-461
48. Crook J.M., Potters L., Stock R.G., et al. Critical organ dosimetry in permanent seed prostate brachytherapy: Defining the organs at risk. Brachytherapy 4 (2005) 186-194
49. Merrick G.S., Butler W.M., Dorsey A.T., et al. The dependence of prostate postimplant dosimetric quality on CT volume determination. Int J Radiat Oncol Biol Phys 44 (1999) 1111-1117
50. Stone N.N., Stock R.G., and Unger P. Intermediate term biochemical-free progression and local control following 125iodine brachytherapy for prostate cancer. J Urol 173 (2005) 803-807
51. Taussky D., Austen L., Toi A., et al. Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion. Int J Radiat Oncol Biol Phys 62 (2005) 974-980
52. Bice Jr. W.S., Prestidge B.R., Grimm P.D., et al. Centralized multi-institutional postimplant analysis for interstitial prostate brachytherapy. Int J Radiat Oncol Biol Phys 41 (1998) 921-927
53. Helmick R., Tarver R., Chan R., et al. Evaluation of post-plan dosimetry using TRUS and CT after transperineal prostate seed implant. Med Dosim 27 (2002) 289-293
54. Kagawa K., Lee W.R., Schultheiss T.E., et al. Initial clinical assessment of CT-MRI image fusion software in localization of the prostate for 3D conformal radiation therapy. Int J Radiat Oncol Biol Phys 38 (1997) 319-325
55. Moerland M.A., Wijrdeman H.K., Beersma R., et al. Evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging. Int J Radiat Oncol Biol Phys 37 (1997) 927-933